J0593 Injection., lanadelumab-flyo, 1 milligrams
J-Codes
Also known as: lanadelumab-flyo, Takhzyro
Lanadelumab-flyo injection, 1 milligram, a monoclonal antibody against plasma kallikrein for prophylaxis of hereditary angioedema attacks.
Clinical Context
First monoclonal antibody approved for hereditary angioedema (HAE) prophylaxis, targeting contact system activation. Administered subcutaneously every 2 or 4 weeks based on patient response.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.